Focal Medical, Inc. (acquired by Continuity Biosciences) logo

Focal Medical, Inc. (acquired by Continuity Biosciences)

We are developing novel targeted therapeutic products based on our innovative local drug-delivery technology platforms.

4 employees · est. 2015 · Cary, United States

VS
Synthonics, Inc. logo

Synthonics, Inc.

Innovative pharmaceutical solutions enhancing absorption and maximizing therapeutic benefits through proprietary metal coordination chemistry.

11 employees · est. 2006 · Blacksburg, United States

Synthonics, Inc. is the older company (2015 vs 2006); Synthonics, Inc. is the larger of the two.

Side-by-Side Comparison

Focal Medical, Inc. (acquired by Continuity Biosciences) Synthonics, Inc.
Founded
2015 2006 older
Headquarters
Cary, United States Blacksburg, United States
Employees
4 11 larger
Industry
Biopharma, Biotechnology, Medical Devices Biotechnology, Pharmaceutical
Funding Stage
Series A Series Unknown
Total Funding
$12.47M $3.10M
Funding Rounds
2 2
Services
Development of Energy-Based Drug Delivery Systems, Local Drug Delivery for Solid Tumors, Clinical Research and Trials for Oncology Therapeutics, Laparoscopic Implantation Techniques Not tracked yet
Target Customers
Oncologists, Cancer Treatment Centers, Clinical Research Organizations, Patients with Intractable Solid Tumors, Biomedical Engineers Not tracked yet
Taxonomy
Biopharmaceutical, Local Drug-delivery, Targeted Therapeutics, Innovative Technology, Pancreatic Cancer Treatment, Non-circulatory Drug Delivery, Patent Protected, Oncology, Gemcitabine Delivery, Advanced Chemotherapy Pharmaceuticals, Drug Discovery, Metal Coordination Chemistry, Therapeutic Benefits, Proprietary Technology, Absorption Enhancement
Website
focalmedical.co synthonicsinc.com
Focal Medical, Inc. (acquired by Continuity Biosciences) logo

About Focal Medical, Inc. (acquired by Continuity Biosciences)

Focal Medical, Inc., recently acquired by Continuity Biosciences, is a pioneering company in the biopharmaceutical sector, known for its development of targeted therapeutic products through innovative local drug-delivery technologies. Founded in 2015, this United States-based company has made signif...

Synthonics, Inc. logo

About Synthonics, Inc.

Synthonics, Inc. is a privately-held specialty pharmaceutical company revolutionizing the industry through their innovative pharmaceutical solutions. Utilizing proprietary metal coordination chemistry, the company focuses on the discovery and development of patentable drugs with the aim of enhancing...

We will tell you when either one moves

BounceWatch watches Focal Medical, Inc. (acquired by Continuity Biosciences) and Synthonics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Focal Medical, Inc. (a... and Synthonics, Inc. — by email.

Frequently Asked Questions

Focal Medical, Inc. (acquired by Continuity Biosciences) — We are developing novel targeted therapeutic products based on our innovative local drug-delivery technology platforms.. Synthonics, Inc. — Innovative pharmaceutical solutions enhancing absorption and maximizing therapeutic benefits through proprietary metal coordination chemistry. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Focal Medical, Inc. (acquired by Continuity Biosciences) has raised $12.47M while Synthonics, Inc. has raised $3.10M.
Focal Medical, Inc. (acquired by Continuity Biosciences) and Synthonics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Focal Medical, Inc. (acquired by Continuity Biosciences) with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Focal Medical, Inc. (acquired by Continuity Biosciences) on 11 Mar 2026, and Synthonics, Inc. on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy